Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Metformin does not compromise energy status in human skeletal muscle at rest or during acute exercise: A randomised, crossover trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Hypovolemia and reduced hemoglobin mass in patients with heart failure and preserved ejection fraction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The influence of fibrillin-1 and physical activity upon tendon tissue morphology and mechanical properties in mice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. An exploration of the methods to determine the protein-specific synthesis and breakdown rates in vivo in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Acute intramyocardial lipid accumulation in rats does not slow cardiac conduction per se

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Epigenome- and Transcriptome-wide Changes in Muscle Stem Cells from Low Birth Weight Men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pre-radiotherapy daily exercise training in non-small cell lung cancer: A feasibility study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Molecular mechanisms in skeletal muscle underlying insulin resistance in lean women with polycystic ovary syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

5´AMP-activated protein kinase (AMPK) is a mediator of a healthy metabolic phenotype in skeletal muscle. Metformin may exacerbate the energy disturbances observed during exercise leading to enhanced AMPK activation, and these disturbances may provoke early muscular fatigue. We studied acute (1 day) and short-term (4 days) effects of metformin treatment on AMPK and its downstream signaling network, in healthy human skeletal muscle and adipose tissue at rest and during exercise, by applying a randomized blinded crossover study design in 10 lean men. Muscle and fat biopsies were obtained before and after the treatment period at rest and after a single bout of exercise. Metformin treat ment elicited peak plasma and muscle metformin concentrations of 31 μM and 11 μM, respectively. Neither of the treatments affected AMPK activity in skeletal muscle and adipose at rest or during exercise. In contrast, whole-body stress during exercise was elevated as indicated by increased plasma lactate and adrenaline concentrations as well as increased heart rate and rate of perceived exertion. Also whole-body insulin sensitivity was enhanced by 4 days metformin treatment, that is reduced fasting plasma insulin and HOMA-IR. In conclusion, acute and short-term metformin treatment does not affect energy homeostasis and AMPK activation at rest or during exercise in skeletal muscle and adipose tissue of healthy subjects. However, metformin treatment is accompanied by slightly enhanced perceived exertion and whole-body stress which may provoke a lesser desire for physical activity in the metformin-treated patients.

OriginalsprogEngelsk
TidsskriftPhysiological Reports
Vol/bind7
Udgave nummer23
Sider (fra-til)e14307
ISSN2051-817X
DOI
StatusUdgivet - dec. 2019

Bibliografisk note

© 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society.

ID: 58646299